Freshfields LLP has advised argenx. Wilson Sonsini Goodrich & Rosati, P.C. has advised Forte Biosciences. Argen NV ADR (NASDAQ: ARGX) and Forte Biosciences, Inc. (NASDAQ: FBRX)...
argenx Acquires Forte Biosciences for $2.2 Billion, Adding First-in-Class Anti-CD122 Antibody to Immunology Pipeline
Legend Biotech Announces $226 Million Public Offering of ADSs
Wilson Sonsini Goodrich & Rosati, Professional Corporation has advised the underwriters with respect to U.S. federal securities law and New York State law. Cooley LLP has...
Whitehawk Therapeutics Announces $87.5 Million Private Placement Financing
Wilson Sonsini Goodrich & Rosati has advised Whitehawk Therapeutics. Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company, has announced that it has entered into a securities...
Windward Bio Group Secures USD 165 Million in Series B Financing Round
Homburger has advised Windward Bio Group AG. Wilson Sonsini Goodrich & Rosati and BGParnter have advised OrbiMed, Novo Holdings, Blue Owl Healthcare Opportunities, and Omega Funds....
Agero to Acquire Urgently in $5.50 Per Share Cash Transaction
Morgan, Lewis & Bockius LLP has advised Agero, Inc., and Wilson Sonsini Goodrich & Rosati has advised Urgently. Agero, Inc., a leading provider of software-enabled driver...
Forte Biosciences Announces $150 Million Public Offering of Common Stock
Wilson Sonsini Goodrich & Rosati has advised Forte Biosciences. Paul Hastings LLP has advised Guggenheim Securities and Barclays. Forte Biosciences, Inc., a clinical-stage biopharmaceutical company specializing...